ACPHARM in Queensland has been issued with infringement notices from the Therapeutic Goods Administration (TGA) for the alleged unlawful advertising of medicinal cannabis.
The Brisbane-based compounding pharmacy has been issued five infringement notices totalling almost $100,000 for the alleged unlawful advertising of therapeutic goods in contravention of the Therapeutic Goods Act 1989.
ACPHARM has since paid the infringement notices, after it was accused of unlawfully advertising medicinal cannabis that is not included in the Australian Register of Therapeutic Goods (ARTG).
Advertising prescription-only medicines, such as medicinal cannabis, directly to consumers, is prohibited under the Act, with the TGA saying such actions can create inappropriate demand and undermine the relationship between patients and their treating medical practitioners.
Therapeutic goods must also be entered in the ARTG before they can be lawfully manufactured, supplied, or advertised in Australia.
It is also alleged ACPHARM promoted the use of a therapeutic good for the treatment of serious diseases, conditions, or disorders, which is also prohibited, unless approved by the TGA.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Nov 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Nov 25
